Dr Zaruhi Poghosyan
Teams and roles for Zaruhi Poghosyan
Publication
2024
2019
2012
2009
2008
2004
Articles
- Antwi, F. D. et al. 2024. Tigilanol tiglate-induced changes in secretome profiles alter c-Met phosphorylation and cell surface protein expression in H357 head and neck cancer cells. Cells 13 (11) 982. (10.3390/cells13110982)
- Bounacer, A. et al., 2004. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways. Oncogene 23 (47), pp.7839-7845. (10.1038/sj.onc.1208085)
- Hiscox, S. E. et al. 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12 458. (10.1186/1471-2407-12-458)
- Maretzky, T. et al., 2009. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Cancer Research 69 (11), pp.4573-4576. (10.1158/0008-5472.CAN-08-4766)
- Mattern, J. et al. 2019. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Scientific Reports 9 (1) 12540. (10.1038/s41598-019-49021-3)
- McLaren, J. E. et al. 2009. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells. Journal of General Virology 90 (9), pp.2239-2250. (10.1099/vir.0.011627-0)
- Zhong, J. L. et al., 2008. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Molecular Cancer Research 6 (3), pp.383-394. (10.1158/1541-7786.MCR-07-2028)